Healthcare Realty Trust Incorporated HR
Healthcare Realty Trust operates as a Real Estate Investment Trust (REIT), specializing in the acquisition, development, financing, and active management of income-generating real estate assets, predominantly serving outpatient healthcare providers throughout the United States. By September 30, 2020, its extensive portfolio comprised 211 properties located across 24 states, collectively spanning 15.5 million square feet and valued at approximately $5.5 billion. The company further provided comprehensive leasing and property management solutions for 11.9 million square feet nationwide.
Snapshot
Reported FFO / AFFO / leverage are from the Q1 2026 earnings release (filed 2026-04-30) — 8-K, EX-99.1.
Yield uses the latest declared dividend, annualized (latest regular payout × frequency; special/liquidating distributions excluded) — an announced-but-not-yet-declared change isn't reflected until it has an ex-date. FFO, AFFO and Net debt / Adj. EBITDA are the company's reported figures from its latest earnings 8-K. Price/OCF and payout use GAAP operating cash flow. NAV premium and credit ratings have no free source yet. See Methodology.
Balance sheet (latest FY: 2025)
Debt-maturity ladder, fixed/floating split, secured/unsecured and coverage ratios come from the supplemental — not yet ingested.
Financial history
| FY | Revenue | Net income | D&A | EBITDA | Op. cash flow |
|---|---|---|---|---|---|
| 2025 | $1.18B | $-246.07M | $563.97M | $519.96M | $457.10M |
| 2024 | $1.27B | $-654.49M | $675.15M | $266.62M | $501.62M |
| 2023 | $1.34B | $-278.26M | $730.71M | $717.28M | $499.82M |
| 2022 | $932.64M | $40.90M | $453.08M | $635.71M | $272.75M |
| 2021 | $534.82M | $66.66M | $202.71M | $321.90M | $232.63M |
| 2020 | $735.07M | $52.62M | $303.83M | $357.34M | $470.09M |
Dividends
| Ex-date | Record | Payment | Declared | Amount | Freq. |
|---|---|---|---|---|---|
| 2026-05-11 | 2026-05-11 | 2026-05-22 | 2026-04-30 | $0.24 | Quarterly |
| 2026-02-24 | 2026-02-24 | 2026-03-11 | 2026-02-12 | $0.24 | Quarterly |
| 2025-11-10 | 2025-11-11 | 2025-11-21 | 2025-10-30 | $0.24 | Quarterly |
| 2025-08-14 | 2025-08-14 | 2025-08-28 | 2025-07-31 | $0.24 | Quarterly |
| 2025-05-12 | 2025-05-12 | 2025-05-23 | 2025-05-01 | $0.31 | Quarterly |
| 2025-03-03 | 2025-03-03 | 2025-03-19 | 2025-02-19 | $0.31 | Quarterly |
| 2024-11-12 | 2024-11-12 | 2024-11-27 | 2024-10-29 | $0.31 | Quarterly |
| 2024-08-12 | 2024-08-12 | 2024-08-28 | 2024-07-30 | $0.31 | Quarterly |
| 2024-05-10 | 2024-05-13 | 2024-05-23 | 2024-04-30 | $0.31 | Quarterly |
| 2024-02-23 | 2024-02-26 | 2024-03-14 | 2024-02-13 | $0.31 | Quarterly |
| 2023-11-13 | 2023-11-14 | 2023-11-30 | 2023-10-30 | $0.31 | Quarterly |
| 2023-08-14 | 2023-08-15 | 2023-08-30 | 2023-08-01 | $0.31 | Quarterly |
| 2023-05-15 | 2023-05-16 | 2023-06-02 | 2023-05-02 | $0.31 | Quarterly |
| 2023-03-06 | 2023-03-07 | 2023-03-21 | 2023-02-24 | $0.31 | Quarterly |
| 2022-11-14 | 2022-11-15 | 2022-11-30 | 2022-11-02 | $0.31 | Quarterly |
| 2022-08-12 | 2022-08-15 | 2022-08-30 | 2022-08-03 | $0.11 | Quarterly |
| 2022-07-21 | 2022-07-19 | 2022-07-27 | 2022-07-06 | $4.82 | Special |
| 2022-07-13 | 2022-07-14 | 2022-07-19 | 2022-07-01 | $0.20 | Irregular |
| 2022-05-13 | 2022-05-03 | 2022-05-27 | 2022-05-03 | $0.31 | Quarterly |
| 2022-04-01 | 2022-04-04 | 2022-04-11 | 2022-02-28 | $0.33 | Monthly |
| 2022-02-25 | 2022-02-22 | 2022-03-15 | 2022-02-28 | $0.31 | Irregular |
| 2022-01-03 | 2022-01-04 | 2022-01-11 | 2021-11-04 | $0.33 | Quarterly |
| 2021-11-12 | 2021-11-02 | 2021-11-30 | 2021-11-03 | $0.30 | Quarterly |
| 2021-10-01 | 2021-10-04 | 2021-10-11 | 2021-08-03 | $0.33 | Irregular |
Coverage (payout of operating cash flow): 73.47%. Tax-character split (ordinary / 199A / capital gain / return of capital) — not disclosed (requires the annual allocation release).
Same-store NOI, occupancy, leasing/WALT, top tenants, external-manager fees, development pipeline and (for non-traded vehicles) share-class fees, redemption/gating and NAV methodology are planned modules sourced from supplementals and prospectuses.